SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in NERV — Minerva Neurosciences, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in NERV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$717,764
+$663,766 QoQ
Shares Held
119,131
+489.1% QoQ
Ownership
0.250%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Derivatives in NERV
reported options exposure · as of Dec 31, 2022CallValue
$27,666
CallShares
17,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in NERV
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $717,764 | 119,131 | Shares | Other | 2026-05-15 | |
| 2024-09-30 | $53,998 | 20,224 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $38,082 | 11,938 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $43,036 | 16,681 | Shares | Defined | 2024-05-07 | |
| 2023-09-30 | $74,547 | 10,804 | Shares | Defined | 2023-11-14 | |
| 2022-12-31 | $27,666 | 17,400 | Call | Defined | 2023-02-14 | |
| 2022-09-30 | $162,448 | 17,600 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $196,614 | 59,400 | Call | Defined | 2022-08-15 | |
| 2022-03-31 | $46,722 | 56,292 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $141,930 | 171,000 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $112,549 | 140,512 | Shares | Defined | 2022-04-05 | |
| 2021-12-31 | $53,506 | 66,800 | Put | Defined | 2022-04-05 | |
| 2021-12-31 | $140,335 | 175,200 | Call | Defined | 2022-04-05 | |
| 2021-09-30 | $336,232 | 193,237 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $229,506 | 131,900 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $361,572 | 207,800 | Call | Defined | 2021-11-15 | |
| 2021-06-30 | $140,360 | 60,500 | Put | Defined | 2021-08-11 | |
| 2021-06-30 | $107,427 | 46,305 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $269,584 | 116,200 | Call | Defined | 2021-08-11 | |
| 2021-03-31 | $214,328 | 73,400 | Put | Defined | 2021-05-17 | |
| 2021-03-31 | $69,980 | 23,966 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $120,304 | 41,200 | Call | Defined | 2021-05-17 | |
| 2020-12-31 | $163,098 | 69,700 | Put | Defined | 2021-02-16 | |
| 2020-12-31 | $202,049 | 86,346 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $27,846 | 11,900 | Call | Defined | 2021-02-16 | |
| 2020-09-30 | $254,673 | 80,086 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $92,538 | 29,100 | Call | Defined | 2020-11-16 | |
| 2020-09-30 | $246,450 | 77,500 | Put | Defined | 2020-11-16 | |
| 2020-06-30 | $1,190,217 | 329,700 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $1,266,637 | 350,869 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $149,454 | 41,400 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $1,509,105 | 250,682 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $2,273,152 | 377,600 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $538,790 | 89,500 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||